The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Rachel.Livingstone@glasgow.ac.uk
Institute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ
Livingstone, R. , Bryant, N. J., Boyle, J. G., Petrie, J. R. and Gould, G. W. (2022) Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle. Endocrinology, Diabetes and Metabolism, 5(5), e361. (doi: 10.1002/edm2.361) (PMID:35964329) (PMCID:PMC9471587)
Black, H. L. et al. (2022) Knockout of Syntaxin-4 in 3T3-L1 adipocytes reveals new insight into GLUT4 trafficking and adiponectin secretion. Journal of Cell Science, 135(1), jcs258375. (doi: 10.1242/jcs.258375) (PMID:34859814) (PMCID:PMC8767277)
Livingstone, R. , Boyle, J.G. and Petrie, J.R. (2020) How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes? Diabetic Medicine, 37(4), pp. 513-521. (doi: 10.1111/dme.13911) (PMID:30697804)
Boyle, J. G., Livingstone, R. and Petrie, J. R. (2018) Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review. Clinical Science, 132(15), pp. 1699-1709. (doi: 10.1042/CS20171299) (PMID:30115742)
Livingstone, R. , Boyle, J. G. and Petrie, J. R. (2017) A new perspective on metformin therapy in type 1 diabetes. Diabetologia, 60(9), pp. 1594-1600. (doi: 10.1007/s00125-017-4364-6) (PMID:28770327)
Laidlaw, K. M.E., Livingstone, R. , Al-Tobi, M. , Bryant, N. J. and Gould, G. W. (2017) SNARE phosphorylation: a control mechanism for insulin-stimulated glucose transport and other regulated exocytic events. Biochemical Society Transactions, 45(6), pp. 1271-1277. (doi: 10.1042/BST20170202) (PMID:29101310)
Livingstone, R. and Boyle, J. (2015) Improving the quality of assessment and management of hypoglycaemia in hospitalised patients with diabetes mellitus by introducing 'hypo boxes' to general medical wards with a specialist interest in diabetes. BMJ Quality Improvement Reports, 4(1), u207686.w3. (doi: 10.1136/bmjquality.u207686.w3067)
Livingstone, R., Fisher, M. and McKay, G. (2015) Do we need another SGLT2 inhibitor? Practical Diabetes, 32(2), 47-48a. (doi: 10.1002/pdi.1920)
Livingstone, R., Fisher, M. and McKay, G. (2014) Apixaban. Practical Diabetes, 31(6), 262-263a. (doi: 10.1002/pdi.1880)
Livingstone, R. , Bryant, N. J., Boyle, J. G., Petrie, J. R. and Gould, G. W. (2022) Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle. Endocrinology, Diabetes and Metabolism, 5(5), e361. (doi: 10.1002/edm2.361) (PMID:35964329) (PMCID:PMC9471587)
Black, H. L. et al. (2022) Knockout of Syntaxin-4 in 3T3-L1 adipocytes reveals new insight into GLUT4 trafficking and adiponectin secretion. Journal of Cell Science, 135(1), jcs258375. (doi: 10.1242/jcs.258375) (PMID:34859814) (PMCID:PMC8767277)
Livingstone, R. , Boyle, J.G. and Petrie, J.R. (2020) How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes? Diabetic Medicine, 37(4), pp. 513-521. (doi: 10.1111/dme.13911) (PMID:30697804)
Boyle, J. G., Livingstone, R. and Petrie, J. R. (2018) Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review. Clinical Science, 132(15), pp. 1699-1709. (doi: 10.1042/CS20171299) (PMID:30115742)
Livingstone, R. , Boyle, J. G. and Petrie, J. R. (2017) A new perspective on metformin therapy in type 1 diabetes. Diabetologia, 60(9), pp. 1594-1600. (doi: 10.1007/s00125-017-4364-6) (PMID:28770327)
Laidlaw, K. M.E., Livingstone, R. , Al-Tobi, M. , Bryant, N. J. and Gould, G. W. (2017) SNARE phosphorylation: a control mechanism for insulin-stimulated glucose transport and other regulated exocytic events. Biochemical Society Transactions, 45(6), pp. 1271-1277. (doi: 10.1042/BST20170202) (PMID:29101310)
Livingstone, R. and Boyle, J. (2015) Improving the quality of assessment and management of hypoglycaemia in hospitalised patients with diabetes mellitus by introducing 'hypo boxes' to general medical wards with a specialist interest in diabetes. BMJ Quality Improvement Reports, 4(1), u207686.w3. (doi: 10.1136/bmjquality.u207686.w3067)
Livingstone, R., Fisher, M. and McKay, G. (2015) Do we need another SGLT2 inhibitor? Practical Diabetes, 32(2), 47-48a. (doi: 10.1002/pdi.1920)
Livingstone, R., Fisher, M. and McKay, G. (2014) Apixaban. Practical Diabetes, 31(6), 262-263a. (doi: 10.1002/pdi.1880)
https://orcid.org/0000-0003-0950-5016